Christopher Bauer, MD
Clinical Cardiac Electrophysiology · Saint Louis, MONPI 1437123254
Payments from drug & device makers
Across 680 payments — averaging $56.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Abbott$11K
- Biotronik Inc.$7K
- Boston Scientific$4K
- Biosense Webster, Inc.$2K
- Cvrx, Inc.$1K
- plus $763 from 21 others
What the payments were for
- Consulting fees$2,0005%
- Speaking & faculty fees$1,2503%
- Travel & lodging$7,85720%
- Food & beverage$27,33371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 198 | $12,284 |
| Abbott | 232 | $11,447 |
| Biotronik Inc. | 71 | $6,935 |
| Boston Scientific | 58 | $3,745 |
| Biosense Webster, Inc. | 75 | $2,051 |
| Cvrx, Inc. | 15 | $1,216 |
| Impulse Dynamics (USA) Inc. | 1 | $146 |
| Atricure, Inc. | 1 | $94 |
| Novo Nordisk | 5 | $75 |
| Cardiva Medical, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $56 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $39 |
| AbbVie | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Amgen | 1 | $23 |
| Dentsply Sirona Inc | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $21 |
| Novartis | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| AstraZeneca | 1 | $16 |
| Vertex | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| GE HealthCare | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$5,760
- AVEIR$1,728
- ENSITE$1,367
- Barostim Neo System$808
- EMBLEM$750
- Carto 3$668
- Acticor 7 VR-T DX$512
- Ensite Cardiac Mapping System$367
- AURORA EV-ICD MRI SURESCAN$294
- OPTIMIZER$293
- Farapulse$273
- QDOT MICRO Catheter$270
- GENERAL BRADY$250
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$250
- RhythmVIEW Work Stations$185
- ASSURITY$175
- GALLANT$161
- AMVIA EDGE$150
- Visia AF$148
- GENERAL - THERAPIES$146
How this compares
$38,441 in reported general payments places this provider in the 60th percentile of 74 clinical cardiac electrophysiology providers in Missouri.
See all clinical cardiac electrophysiology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 486 | $507,434 |
| EntrestoSacubitril/Valsartan | 62 | $53,159 |
| MultaqDronedarone Hcl | 31 | $45,589 |
| XareltoRivaroxaban | 33 | $38,296 |
| Dofetilide | 75 | $19,902 |
| JardianceEmpagliflozin | 13 | $19,725 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 20 | $4,352 |
| Metoprolol Succinate | 287 | $3,966 |
| SotalolSotalol Hcl | 93 | $2,406 |
| Amiodarone Hcl | 178 | $2,160 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 53 | $2,151 |
| Colchicine | 15 | $1,063 |
| Metoprolol Tartrate | 91 | $954 |
| Mupirocin | 91 | $700 |
| Carvedilol | 49 | $439 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $20 | $53,15962 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 74 clinical cardiac electrophysiology providers in Missouri.
Other clinical cardiac electrophysiology in Saint Louis
- Daniel CooperSaint Louis$1.5M
- Phillip CuculichSaint Louis$478K
- Timothy SmithSaint Louis$454K
- Mitchell FaddisSaint Louis$342K
- Marye GlevaSaint Louis$321K
- Amit DoshiSaint Louis$154K
- Paban SahaSaint Louis$92K
- Saulius KalvaitisSaint Louis$89K
- Philip MarSaint Louis$66K
- Krasimira MikhovaSaint Louis$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.